Nixon Comments on “Familial AD Mutations, β-CTF, Spell Trouble for Endosomes”

New York – Dr. Ralph Nixon, Director of the CDR, is a regular commentator of the Alzforum website.  His recent comment posted on August 19, calls the report on CRISPR-modified IPSC neurons expressing diverse APP and PSEN1 FAD mutations a technical tour de force.